GENEVA, June 19 -- MEMORIAL SLOAN-KETTERING CANCER CENTER filed a patent application (US2024/053498) for “BIOMARKERS AND USES THEREOF FOR TREATMENT OF CANCER WITH CD19-TARGETED ADOPTIVE CELL THERAPIES”. With publication no. WO/2025/096493, here are the other details related to the patent application:
Kind: Correction of entry in Section I of the PCT Gazette [A8]
IPC: A61P 35/02
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....